S-(+)-N-Trifluoroacetodesmethylicitalopram, identified by its CAS number 1217697-83-0, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). This compound is a derivative of citalopram, which is primarily used in the treatment of depression and anxiety disorders. The presence of the trifluoroacetyl group in its structure enhances its pharmacological properties. Characteristically, it exhibits a chiral center, which contributes to its enantiomeric specificity, often influencing its biological activity and therapeutic efficacy. The compound is typically characterized by its molecular weight, solubility in organic solvents, and stability under various conditions. Its synthesis and characterization involve standard organic chemistry techniques, including NMR and mass spectrometry for structural confirmation. As with many SSRIs, understanding its mechanism of action involves studying its interaction with serotonin transporters, which is crucial for its antidepressant effects. Safety and toxicity profiles are also essential considerations in its pharmacological evaluation.

S-(+)-N-TRIFLUOROACETODESMETHYLCITALOPRAM

1217697-83-0: S-(+)-N-Trifluoroacetodesmethylicitalopram, identified by its CAS number 1217697-83-0, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). This compound is a derivative of citalopram, which is primarily used in the treatment of depression and anxiety disorders. The presence of the trifluoroacetyl group in its structure enhances its pharmacological properties. Characteristically, it exhibits a chiral center, which contributes to its enantiomeric specificity, often influencing its biological activity and therapeutic efficacy. The compound is typically characterized by its molecular weight, solubility in organic solvents, and stability under various conditions. Its synthesis and characterization involve standard organic chemistry techniques, including NMR and mass spectrometry for structural confirmation. As with many SSRIs, understanding its mechanism of action involves studying its interaction with serotonin transporters, which is crucial for its antidepressant effects. Safety and toxicity profiles are also essential considerations in its pharmacological evaluation.

CAS 1217697-83-0

S-(+)-N-TRIFLUOROACETODESMETHYLCITALOPRAM